🔎 Trials Near Me

Gara Jalqabaatti › Gliosarcoma

Qorannoo klinikaalii Gliosarcoma Ameerikaa Keessatti hirmaatuu

Qorannoo 10 Gliosarcoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07301268

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT03896568

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07089641

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05698524

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06934889

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Namoota walitti qabaa jiraSadarkaa 1
36 Months – 22 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03911388

Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT04991870

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Gur-2026 · NCT05756985

Study of Pembrolizumab and M032 (NSC 733972)

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT05084430

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Mud-2025 · NCT04541082

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.